PTEN and ovarian carcinoma: Likewise, in PEO1 ovarian cancer cells, PTEN knockdown activated Src kinase and increased EphA2 expression, whereas inhibiting Src with dasatinib potently suppressed Src phosphorylation and reduced EphA2 expression (Fig. 7H).